International

Grant agreement number: (no. EURONANOMED2-01/2014) Aim of the project: Project aimed to develop and validate a novel, non-invasive, easy to use and low-cost tool for screening, early detection of GC, CRC and the related premalignant lesions in individualized patient care. Source of funding: EuroNanoMedII

Grant agreement number: (no. S-59 / 2022-PRO00032) Aim of the project: To identify and compare changes in nutrition, metagenomic factors, metabolite, and microRNAprofile and to evaluate the interaction of these gastric microenvironmental factors in Helicobacter pylori induced gastriccarcinogenesis. Source of funding: Ministry of Health of The Republic of Lithuania (SAM) and Japan Agency for Medical Research andDevelopment (AMED)

Grant agreement number: (no. 2024-PRO00128) Aim of the project: To pioneer a novel approach to early PDAC detection in Taiwan and Lithuania using proteomics andadvanced full spectrum metabolite analysis in serum, including key clinical data and/or biochemical markers, and coupled with machine learning algorithms to develop a rapid and precise diagnostic tool. Source of funding: LithuaniaTaiwan project funds

Grant agreement number: (no. ECCO Grant 2016) Aim of the project: Project aimed to perform large scale miRNA profiling using next generation sequencing technique and identify whether the changes of miRNA expression can be used to discriminate active UC and patients in clinicaland endoscopic remission on tissue and epithelial cell plasma level. Source of funding: European Crohn’s and

Grant agreement number: (no. VP1-3.1- ŠMM07-K-01-156) Aim of the project: Project aimed to determine the expression profile of miRNAs associated with cancer processes inpatients with gastric and colorectal cancer and premalignant diseases to evaluate the suitability of these markers forearly and noninvasive diagnosis of diseases. Source of funding: EU Structural Fund

Grant agreement number: (no. 13.1.1-LMT-K718-05-0023) Aim of the project: Project aimed to expand applied knowledge and develop a digital tool for assessment of changes in the rate of evolution of emerging SARSCoV-2 lineages and the potential impact of new virus lineages on immune vaccine efficacy) and clinical response, through the implementation of high-level scientific research project in

Grant agreement number: (no. 09.3.3-LMT-K-712-01-0130) Aim of the project: To determine the profile of circulating genetic, epigenetic and blood-derived microbiome biomarkers in gastric cancer and precancerous gastric conditions and evaluate the suitability of these biomarkers for noninvasive diagnosis, monitoring and prognosis of the diseases. Source of funding: EU Structural Fund

Grant agreement number: r (no. 01.2.2-LMT-K-718-03-0086) Aim of the project: Project aims to develop a multicomponent molecular test for non-invasive colorectal cancer screening, through the implementation of the innovative world-class project in the field of Natural Sciences, Source of funding: EU Structural Fund

Grant agreement number: (no. S-BMT-21-9 (LT08-2-LMT-K-01-041)) Aim of the project: By using in vitro and in vivo models, including patientderived xenografts, project aimed to evaluate the potential of AHR inhibition in PC therapy, assess the activities of AHR and ELAVL1 pathways in PC patients, to determine the subsets of patients who would benefit most from AHR inhibition,

Grant agreement number: (no. S-BMT-21-11 (LT08-2-LMT-K-01-060)) Aim of the project: Project aimed to determine circulating blood microbiome signatures in inflammatory bowel and related autoimmune liver diseases by implementing advanced collaborative multidisciplinary research project betweenNorwegian and Baltic States research institutions. Source of funding: European Economic Area (EEA) (Iceland, Liechtenstein, Norway) Financial Mechanism 2014-2021